ATE128233T1 - Zellnekrosnachweis durch prüfung von spektrin und seine abbauprodukte. - Google Patents

Zellnekrosnachweis durch prüfung von spektrin und seine abbauprodukte.

Info

Publication number
ATE128233T1
ATE128233T1 AT91913322T AT91913322T ATE128233T1 AT E128233 T1 ATE128233 T1 AT E128233T1 AT 91913322 T AT91913322 T AT 91913322T AT 91913322 T AT91913322 T AT 91913322T AT E128233 T1 ATE128233 T1 AT E128233T1
Authority
AT
Austria
Prior art keywords
spectrin
bdp
detection
necros
testing
Prior art date
Application number
AT91913322T
Other languages
English (en)
Inventor
Gary S Lynch
David D Eveleth Jr
Peter A Seubert
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE128233T1 publication Critical patent/ATE128233T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/561Immunoelectrophoresis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT91913322T 1990-07-26 1991-07-11 Zellnekrosnachweis durch prüfung von spektrin und seine abbauprodukte. ATE128233T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/558,700 US5118606A (en) 1988-09-02 1990-07-26 Methods for detecting cellular pathology by assaying spectrin and spectrin breakdown products

Publications (1)

Publication Number Publication Date
ATE128233T1 true ATE128233T1 (de) 1995-10-15

Family

ID=24230602

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91913322T ATE128233T1 (de) 1990-07-26 1991-07-11 Zellnekrosnachweis durch prüfung von spektrin und seine abbauprodukte.

Country Status (10)

Country Link
US (1) US5118606A (de)
EP (1) EP0540591B1 (de)
JP (2) JP2824150B2 (de)
AT (1) ATE128233T1 (de)
CA (1) CA2088050A1 (de)
DE (1) DE69113273T2 (de)
DK (1) DK0540591T3 (de)
ES (1) ES2077863T3 (de)
GR (1) GR3017459T3 (de)
WO (1) WO1992001935A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444042A (en) * 1990-12-28 1995-08-22 Cortex Pharmaceuticals Method of treatment of neurodegeneration with calpain inhibitors
US5536639A (en) * 1994-03-25 1996-07-16 Cephalon, Inc. Methods for detecting calpain activation by detection of calpain activated spectrin breakdown products
CA2188816C (en) 1996-04-23 2009-09-22 Takeda Chemical Industries, Ltd. Composition containing .alpha.-fodrin or .alpha.- fodrin fragment protein
US6011991A (en) * 1998-12-07 2000-01-04 Technology Patents, Llc Communication system and method including brain wave analysis and/or use of brain activity
JP2005538380A (ja) * 2002-09-11 2005-12-15 ユニヴァーシティ オヴ フロリダ 神経細胞損傷の分析
AU2005238446B2 (en) 2004-04-15 2009-07-30 Banyan Biomarkers Inc. Neural proteins as biomarkers for nervous system injury and other neural disorders
US8492107B2 (en) 2004-04-15 2013-07-23 University Of Florida Research Foundation, Inc. Neural proteins as biomarkers for nervous system injury and other neural disorders
ES2367311T3 (es) * 2004-04-15 2011-11-02 University Of Florida Research Foundation, Inc. Productos de degradación proteolítica de map-2 como biomarcadores de diagnóstico para las lesiones neurales.
WO2008097618A1 (en) * 2007-02-06 2008-08-14 University Of Florida Research Foundation, Inc. Synaptotagmin and collapsin response mediator protein as biomarkers for traumatic brain injury
CN101970491A (zh) 2007-08-30 2011-02-09 沃尔特及伊莱萨霍尔医学研究院 树突状细胞标记物及其用途
AU2009282117B2 (en) 2008-08-11 2016-05-12 Banyan Biomarkers, Inc. Biomarker detection process and assay of neurological condition
US12601749B2 (en) 2008-08-11 2026-04-14 Banyan Biomarkers, Inc. Biomarker detection process and assay of neurological condition
US20120039806A1 (en) * 2009-03-23 2012-02-16 Mireille Hanna Lahoud Compounds and Methods for Modulating an Immune Response
CA2774411A1 (en) * 2009-09-18 2011-03-24 Geert W. Schmid-Schonbein Methods for detecting autodigestion
EP2621521A4 (de) 2010-10-02 2014-04-23 Univ California Minimierung von darmdysfunktionen
WO2012170669A1 (en) * 2011-06-07 2012-12-13 Yale University Avenue Biomarkers for assessment of the molecular quality in biospecimens
EP3532496A1 (de) 2016-10-28 2019-09-04 Banyan Biomarkers, Inc. Antikörper gegen ubiquitin c-terminale hydrolase l1 (uch-l1) und gliales fibrilläres saures protein (gfap) und verwandte verfahren
WO2019060298A1 (en) 2017-09-19 2019-03-28 Neuroenhancement Lab, LLC METHOD AND APPARATUS FOR NEURO-ACTIVATION
US11717686B2 (en) 2017-12-04 2023-08-08 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to facilitate learning and performance
US11318277B2 (en) 2017-12-31 2022-05-03 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to enhance emotional response
US12280219B2 (en) 2017-12-31 2025-04-22 NeuroLight, Inc. Method and apparatus for neuroenhancement to enhance emotional response
US11364361B2 (en) 2018-04-20 2022-06-21 Neuroenhancement Lab, LLC System and method for inducing sleep by transplanting mental states
CN113382683A (zh) 2018-09-14 2021-09-10 纽罗因恒思蒙特实验有限责任公司 改善睡眠的系统和方法
US11786694B2 (en) 2019-05-24 2023-10-17 NeuroLight, Inc. Device, method, and app for facilitating sleep
WO2021108380A1 (en) * 2019-11-26 2021-06-03 Ohio State Innovation Foundation Methods and compositions for cardiovascular disease detection and management

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990002949A1 (en) 1988-09-02 1990-03-22 The Regents Of The University Of California Method for detecting cellular pathology

Also Published As

Publication number Publication date
DE69113273T2 (de) 1996-05-15
CA2088050A1 (en) 1992-01-27
WO1992001935A1 (en) 1992-02-06
DE69113273D1 (de) 1995-10-26
JP2824150B2 (ja) 1998-11-11
ES2077863T3 (es) 1995-12-01
JPH1130615A (ja) 1999-02-02
EP0540591A1 (de) 1993-05-12
EP0540591B1 (de) 1995-09-20
US5118606A (en) 1992-06-02
DK0540591T3 (da) 1996-02-05
JPH05508919A (ja) 1993-12-09
GR3017459T3 (en) 1995-12-31

Similar Documents

Publication Publication Date Title
DE69113273D1 (de) Zellnekrosnachweis durch prüfung von spektrin und seine abbauprodukte.
Blancher et al. SDS-PAGE and western blotting techniques
ATE164683T1 (de) Schnelles immunologisches testverfahren zum nachweis von antikörpern oder antigenen einschliesslich gleichzeitiger nachweis probenextraktion und immunogener reaktion
IT8019675A0 (it) Procedimento per rivelare ligandi in campioni di prova e relativo reagente analitico.
ES2192611T3 (es) Procedimiento de eliminacion de la interferencia del factor reumatoide en los dosificados de diagnostico.
IT1190152B (it) Provino per la valutazione dei risultati di esami non distruttivi di materiali,nonche' elementi di difetto e procedimento per preparare provini
ATE128237T1 (de) Test für hepatitis-c.
Ronald Review of current techniques for the verification of the species origin of meat
Kristensen et al. Expression of Na+/HCO3− co‐transporter proteins (NBCs) in rat and human skeletal muscle
ES501734A0 (es) Un procedimiento para la deteccion de anticuerpos en una muestra de ensayo
ATE397215T1 (de) Entstörung von immunoassays durch substanzen, die aus den framework-regionen von antikörpern abgeleitet sind
Silvestrini et al. Changes in concanavalin A-reactive proteins in inflammatory disorders.
EP0254081A3 (de) Verfahren zur Feststellung spezifisches Protein
DE68922126D1 (de) Immunometrisches Verfahren zum Nachweis von Lipoprotein-Teilchen, anti-Lp(a) Monoklonale Antikörper und ihre Anwendung zur Diagnose von Atherosklerose.
DK33991A (da) Fremgangsmaade til paavisning af cellepatologi
Goodburn et al. A simple micro-ELISA method for the assay of antithyroglobulin autoantibodies in human serum
Pedersen et al. Detection of M-components by an easy immunofixation procedure: comparison with agarose gel electrophoresis and classical immunoelectrophoresis
Nyhlin et al. Evaluation of immunohistochemical staining of human duodenal endocrine cells after microwave antigen retrieval
EP0204579A3 (de) Immunoassay-Inkubationsapparat
DK162726C (da) Fremgangsmaade til eliminering af falsk positive resultater ved bestemmelse af atl virus-antistof og reagens dertil
Näreaho et al. Comparative analysis of Trichinella spiralis and Trichinella nativa proteins by two-dimensional gel electrophoresis
Kirschstein et al. Proteinuria after renal transplantation: Diagnosis with highly sensitive silver stain in sodium dodecylsulphate-polyacrylamide gradient gel electrophoresis
ES504126A0 (es) Un metodo analitico para la determinacion de uno o mas para-metros en muestras de pruebas
Podhradska et al. Effect of inflammation on serum glycoproteins in rabbits
RU94006938A (ru) Способ твердофазного люминесцентного иммуноанализа компонентов биологических жидкостей

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee